Valuation dashboard for Coeptis Therapeutics Holdings, Inc. (COEP) with P/E N/A, P/B 3.50, EV/EBITDA -5.28 and dividend yield 0.00%. DCF, Graham Number and Earnings Power Value models plus sector comparison against other Technology companies.
Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, operates as a biopharmaceutical and technology company. The company is developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Its therapeutic portfolio includes an allogeneic cellular immunotherapy platform; and DVX201, a clinical-stage, unmodified natural killer cell therapy technology.
Analysis Summary
Coeptis Therapeutics Holdings, Inc. reported revenue of $1.4M in the most recent fiscal year, growing at a 5-year CAGR of 113.5%.
Trailing-twelve-month margins: gross margin 86.7%, operating margin -9.6%, net margin -8.7%.
At the current price of $10.99, COEP has negative trailing earnings (P/E not meaningful) and an ROE of -69.09%. Market capitalisation stands at $39M.
Balance sheet quality for COEP: current ratio of 4.2. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 3.50 |
| EV / EBITDA | -5.28 |
| Dividend Yield | 0.00% |
Valuation Models
| DCF Fair Value | $3.02 |
| vs Current Price | -72.5% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| COEP | Coeptis Therapeutics Holdings, Inc. | $39M | 3.50 | -69.1% | |
| 0LP3.L | Verisk Analytics, Inc. | $23.7B | |||
| VRSK | Verisk Analytics, Inc. | $23.2B | 27.88 | 293.9% | |
| CART | Maplebear Inc. | $11.0B | 23.33 | 4.48 | 17.6% |
| BITF.TO | Keel Infrastructure Corp. | $4.7B | 2.34 | -37.2% |
Price
| Price | $10.99 |
| Market Cap | $39M |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -69.09% |
| Return on Invested Capital | -71.70% |
| Return on Assets | -60.06% |
| Gross Margin | 86.75% |
| Operating Margin | -956.94% |
| Net Margin | -874.29% |
Related companies: CUE · EQ · IPSC · KPTI · MDCX · NRXP · OSTX
Explore sector: Technology · Software - Services
More sections of COEP: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks